Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Efficacy of Omaveloxolone Treatment for Dysphagia in French Patients With Friedreich's Ataxia

View source ↗

Summary

Clinical trial update indicating a study of omaveloxolone for dysphagia in French patients with Friedreich's ataxia, which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omaveloxolone (omaveloxolone)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Friedreich Ataxia | Status: NOT_YET_RECRUITING